Live feed
Filing
SC 13G
SC 13G0000929638-20-001105·Cormorant Asset Management, LP
Schedule 13G ownership disclosure
Olema Pharmaceuticals Inc
Security class unavailable · CUSIP: 68062P106
Event date: 2020-11-23
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 2.3500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000929638-20-001105
- Form type
- SC 13G
- Filer
- Cormorant Asset Management, LP
- CIK
- CIK 1583977
- Filed
- Nov 23, 2020
- Reporting period
- Nov 23, 2020
- Description
- Schedule 13G beneficial ownership